These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24078620)

  • 1. Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states.
    Ades F; Senterre C; de Azambuja E; Sullivan R; Popescu R; Parent F; Piccart M
    Ann Oncol; 2013 Nov; 24(11):2897-902. PubMed ID: 24078620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: the trastuzumab case.
    Ades F; Senterre C; Zardavas D; de Azambuja E; Popescu R; Parent F; Piccart M
    Eur J Cancer; 2014 Dec; 50(18):3089-97. PubMed ID: 25446375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost and burden of cancer in the European Union 1995-2014.
    Jönsson B; Hofmarcher T; Lindgren P; Wilking N
    Eur J Cancer; 2016 Oct; 66():162-70. PubMed ID: 27589247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of cancer across the European Union: a population-based cost analysis.
    Luengo-Fernandez R; Leal J; Gray A; Sullivan R
    Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wealth, Health Expenditure, and Cancer: A National Perspective.
    Chahoud J; Semaan A; Rieber A
    J Natl Compr Canc Netw; 2016 Aug; 14(8):972-8. PubMed ID: 27496113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing social protection influence on health status in the European Union.
    Bocean CG; Vărzaru AA
    Front Public Health; 2024; 12():1287608. PubMed ID: 38528863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequality, poverty, and material deprivation in new and old members of the European Union.
    Matković T; Sucur Z; Zrinscak S
    Croat Med J; 2007 Oct; 48(5):636-52. PubMed ID: 17948950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EURO-MED-STAT: monitoring expenditure and utilization of medicinal products in the European Union countries: a public health approach.
    EURO-MED STAT Group
    Eur J Public Health; 2003 Sep; 13(3 Suppl):95-100. PubMed ID: 14533757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European challenges of funding orphan medicinal products.
    Szegedi M; Zelei T; Arickx F; Bucsics A; Cohn-Zanchetta E; Fürst J; Kamusheva M; Kawalec P; Petrova G; Slaby J; Stawowczyk E; Vocelka M; Zechmeister-Koss I; Kaló Z; Molnár MJ
    Orphanet J Rare Dis; 2018 Nov; 13(1):184. PubMed ID: 30396361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral healthcare systems in the extended European union.
    Widström E; Eaton KA
    Oral Health Prev Dent; 2004; 2(3):155-94. PubMed ID: 15641621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National health expenditures: a global analysis.
    Murray CJ; Govindaraj R; Musgrove P
    Bull World Health Organ; 1994; 72(4):623-37. PubMed ID: 7923542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is public health between East and West? Analysis of wealth, health and mortality in Austria, Central and Eastern European Countries and Croatia relative to the European Union.
    Hofmarcher MM
    Croat Med J; 1998 Sep; 39(3):241-8. PubMed ID: 9740635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Union, economies and public health: not one without the other.
    Vervoort D; van Daalen KR
    Public Health; 2021 May; 194():1-3. PubMed ID: 33836317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
    Vrdoljak E; Bodoky G; Jassem J; Popescu R; Pirker R; Čufer T; Bešlija S; Eniu A; Todorović V; Kopečková K; Kurteva G; Tomašević Z; Sallaku A; Smichkoska S; Bajić Ž; Sikic B
    Oncologist; 2019 Jan; 24(1):e30-e37. PubMed ID: 30181313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EU Country Specific Recommendations for health systems in the European Semester process: trends, discourse and predictors.
    Azzopardi-Muscat N; Clemens T; Stoner D; Brand H
    Health Policy; 2015 Mar; 119(3):375-83. PubMed ID: 25650138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Headline indicators for monitoring the performance of health systems: findings from the european Health Systems_Indicator (euHS_I) survey.
    Perić N; Hofmarcher MM; Simon J
    Arch Public Health; 2018; 76():32. PubMed ID: 29988348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis.
    Stuckler D; Basu S; Suhrcke M; Coutts A; McKee M
    Lancet; 2009 Jul; 374(9686):315-23. PubMed ID: 19589588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comprehensive cancer monitoring programme in Europe.
    Bray F; Guerra Yi M; Parkin DM
    Eur J Public Health; 2003 Sep; 13(3 Suppl):61-6. PubMed ID: 14533751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening in countries of European Council outside of the EU-28.
    Altobelli E; D'Aloisio F; Angeletti PM
    World J Gastroenterol; 2016 May; 22(20):4946-57. PubMed ID: 27239121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.